Epiminder Ltd

Epiminder Ltd

EPI · AU · Healthcare / Medical Devices

0.275AUD+0.01 (+1.85%)

Price History

Full chart

Market Stats

Previous Close0.27
Open0.265
Day Range0.265 – 0.28
52-Week Range0.25 – 1.49
Volume133.55K
Market Cap56.33M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.28
Dividend Yield0.00%
50-Day Avg0.3203
200-Day Avg0.5453

About

Epiminder Limited engages in the development and manufacture of monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. The company offers Minder system, an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. Its Minder system comprises Minder Implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder Wearable, which receives and stores EEG recordings wirelessly transmitted from the Minder implant to the Minder app; Minder App that collects and transmits EEG data from the Minder implant via Bluetooth and uploads to the Minder Cloud for processing; and Minder Cloud, a secure, online portal which allows healthcare professionals to download patient data. The company was incorporated in 2017 and is based in Melbourne, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Rohan J. Hoare Ph.D.
  • HeadquartersWest Podium, Mezzanine 2, Melbourne, VIC, Australia, 3000, Australia
  • Websitehttps://epiminder.com

Leadership

  • Dr. Rohan J. Hoare Ph.D.CEO, MD & Director · b. 1964
  • Prof. Mark Cook A.O.Founder & Chief Medical Officer
  • Mr. Mark McLellanCFO & Company Secretary
  • Dr. John HeasmanChief Operating Officer
  • Mr. Toby McSweeneyChief Technology Officer
  • Ms. Belinda Ann Cleminson BEd, GIA (Cert)Joint Company Secretary

Financials

Income Statement

Currency: AUD2023-06-302024-06-302025-06-302026-06-30
Total Revenue5.49M6.56M445.18K-
Growth (%)-+19.48%-93.22%-
Cost of Revenue---4.00M
Gross Profit----4.00M
Operating Expense---39.65M
Operating Income-15.14M-14.05M-29.84M-43.65M
Operating Margin-275.66%-214.14%-6701.97%-
Net Income-16.08M-15.92M-31.78M-42.73M
Net Income Margin-292.72%-242.54%-7138.46%-
R&D---17.24M
Interest Expense1.01M1.95M3.04M1.22M
Interest Expense % of Total Revenue18.41%29.74%683.94%-

Balance Sheet

Currency: AUD2023-06-302024-06-302025-06-302026-06-30
Total Assets36.58M34.19M130.71M90.84M
Total Liabilities35.19M41.99M23.32M9.17M
Total Equity1.39M-7.79M107.39M81.67M
Cash11.17M11.31M116.95M75.79M

Cash Flow

Currency: AUD2023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-14.25M-13.77M-16.98M-
Investing Cash Flow-25.15K-49.84K-38.15K-
Financing Cash Flow10.38M13.98M14.58M109.99M
Capital Expenditure25.15K49.84K38.15K0

Key Statistics & Ratios

Market Cap56.33M
Enterprise Value-15.13M
Trailing P/E0.00
Forward P/E0.00
Price / Sales26.42
Price / Book0.74
EPS-0.28
Book Value0.377
Revenue (TTM)2.13M
Gross Profit (TTM)2.13M
EBITDA-35.29M
Profit Margin0.00%
Operating Margin-1104.58%
Return on Equity-301.87%
Return on Assets-38.93%
Shares Outstanding216.67M
Shares Float117.33M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%